Connection
Kimi Kondo to Piperazines
This is a "connection" page, showing publications Kimi Kondo has written about Piperazines.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.080 |
|
|
|
-
Jelinek J, Gharibyan V, Estecio MR, Kondo K, He R, Chung W, Lu Y, Zhang N, Liang S, Kantarjian HM, Cortes JE, Issa JP. Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. PLoS One. 2011; 6(7):e22110.
Score: 0.080